CIK 0001604821 · Large accelerated filer
Natera, Inc.
Sign in to watch- Ticker
- NTRA
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 010894487
- Phone
- 650-249-9090
- Business address
- 13011 MCCALLEN PASS, BUILDING A SUITE 100, AUSTIN, TX, 78753
- Former names
- Natera, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $104,832,418
- in 28 filings, $104.8M under 10b5-1 plans
Net −$104,832,418. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Rabinowitz Matthew −$72.3M EXECUTIVE CHAIRMAN sold 9% of stake
- Sheena Jonathan −$13.8M Director sold 83% of stake
- Moshkevich Solomon −$9.5M PRESIDENT, CLINICALDIAGNOSTICS sold 21% of stake
- Chapman Steven Leonard −$5.0M CEO AND PRESIDENT sold 12% of stake
- Brophy Michael Burkes −$2.5M CHIEF FINANCIAL OFFICER sold 11% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-05-01 | Sheena Jonathan Director | Sale 10b5-1 | −107 | $206.16 | $22K | 255,652 |
| 2026-04-29 | Brophy Michael Burkes CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −300 | $190.12 | $57K | 61,061 |
| 2026-04-29 | Brophy Michael Burkes CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −500 | $192.13 | $96K | 60,561 |
| 2026-04-29 | Brophy Michael Burkes CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −1,000 | $193.78 | $194K | 59,561 |
| 2026-04-29 | Brophy Michael Burkes CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −1,070 | $194.82 | $208K | 58,491 |
| 2026-04-29 | Brophy Michael Burkes CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −200 | $197.26 | $39K | 58,291 |
| 2026-04-29 | Sheena Jonathan Director | Sale 10b5-1 | −2,266 | $196.22 | $445K | 256,516 |
| 2026-04-29 | Sheena Jonathan Director | Sale 10b5-1 | −805 | $196.99 | $159K | 255,711 |
| 2026-04-27 | Fesko John PRESIDENT, CHIEF BUS. OFFICER | Sale 10b5-1 | −771 | $203.75 | $157K | 188,428 |
| 2026-04-27 | Fesko John PRESIDENT, CHIEF BUS. OFFICER | Sale 10b5-1 | −917 | $204.39 | $187K | 187,511 |
| 2026-04-27 | Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS | Sale 10b5-1 | −997 | $203.75 | $203K | 146,885 |
| 2026-04-27 | Moshkevich Solomon PRESIDENT, CLINICALDIAGNOSTICS | Sale 10b5-1 | −1,185 | $204.39 | $242K | 145,700 |
| 2026-04-27 | RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER | Sale 10b5-1 | −873 | $203.75 | $178K | 224,012 |
| 2026-04-27 | RABINOWITZ DANIEL SEC. AND CHIEF LEGAL OFFICER | Sale 10b5-1 | −988 | $204.39 | $202K | 223,024 |
| 2026-04-27 | Chapman Steven Leonard CEO AND PRESIDENT | Sale 10b5-1 | −2,272 | $203.75 | $463K | 154,335 |
| 2026-04-27 | Chapman Steven Leonard CEO AND PRESIDENT | Sale 10b5-1 | −3,566 | $204.39 | $729K | 150,769 |
| 2026-04-27 | Brophy Michael Burkes CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −771 | $203.75 | $157K | 62,583 |
| 2026-04-27 | Brophy Michael Burkes CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −1,222 | $204.39 | $250K | 61,361 |
| 2026-04-27 | Sheena Jonathan Director | Sale 10b5-1 | −285 | $203.75 | $58K | 258,970 |
| 2026-04-27 | Sheena Jonathan Director | Sale 10b5-1 | −188 | $204.39 | $38K | 258,782 |
Page 20 of 55 · 1,093 trades